Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Endocrinology, Diabetes & Metabolism|July 1, 2026
Role of Evogliptin for Intra-Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From A Multi-Center, Prospective, Observational Study (REVISE Study)Jie-Eun Lee, Jun Hwa Hong, Sung Hoon Yu, et al.
Diabetes, Obesity & Metabolism|July 9, 2024
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 studyKyung Ah Han, You-Cheol Hwang, Shin Je Moon, et al.
Diabetes, Obesity & Metabolism|April 29, 2026
Efficacy and Safety of Pregabalin and Alpha-Lipoic Acid Combination in Patients With Painful Diabetic Peripheral Neuropathy: A Randomized, Open-Label, Non-Inferiority, Phase IV Clinical Trial and Subgroup Analysis (OPTIMUM Study)Tae Jung Oh, Sang Soo Kim, Seung-Hwan Lee, et al.
Diabetes & Metabolism Journal|September 26, 2023
Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week ExtensionJun Sung Moon, Il Rae Park, Hae Jin Kim, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 15, 2005
Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinaseWoo Je Lee, In Kyu Lee, Hyoun Sik Kim, et al.
Diabetes, Obesity & Metabolism|October 8, 2024
Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III studyJun Hwa Hong, Myung Jin Kim, Kyung Wan Min, et al.
Endocrine Journal|May 24, 2008
Higher serum free thyroxine levels are associated with coronary artery diseaseChan-Hee Jung, Eun-Jung Rhee, Hun-Sub Shin, et al.
Pflugers Archiv : European Journal of Physiology|October 17, 2017
Resistance exercise improves cardiac function and mitochondrial efficiency in diabetic rat heartsTae Hee Ko, Jubert C Marquez, Hyoung Kyu Kim, et al.
Clinical Hypertension|July 31, 2024
Blood pressure control in diabetic kidney disease: a post-hoc analysis of the FANTASTIC trialCheol Ho Park, Soon Jun Hong, Sung Gyun Kim, et al.
Diabetes, Obesity & Metabolism|December 19, 2025
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trialSeung-Hwan Lee, Kyung Ah Han, Eun-Gyoung Hong, et al.
Pageof 9